Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study of CNSA-001 in Women With Moderate to Severe Diabetic Gastroparesis
Conditions
Interventions
CNSA-001
Placebo
Locations
6
United States
GW Research, Inc.
Chula Vista, California, United States
LMG Research
Miami, Florida, United States
Indiana University Hospital
Indianapolis, Indiana, United States
University of Louisville
Louisville, Kentucky, United States
Johns Hopkins University
Baltimore, Maryland, United States
Clinical Research Solutions, LLC
Jackson, Tennessee, United States
Start Date
February 27, 2019
Primary Completion Date
September 8, 2019
Completion Date
October 8, 2019
Last Updated
January 5, 2022
NCT06803589
NCT05229432
NCT03876288
NCT07287943
NCT07324785
NCT05880199
Lead Sponsor
PTC Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions